These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8059829)

  • 1. Different pattern of zymography between human gynecologic normal and malignant tissues.
    Tamakoshi K; Kikkawa F; Nawa A; Maeda O; Kawai M; Sugamuma N; Yamagata S; Tomoda Y
    Am J Obstet Gynecol; 1994 Aug; 171(2):478-84. PubMed ID: 8059829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
    Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
    Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
    Kikkawa F; Tamakoshi K; Nawa A; Shibata K; Yamagata S; Yamagata T; Suganuma N
    Cancer Lett; 1997 Nov; 120(1):109-15. PubMed ID: 9570393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms.
    Tamakoshi K; Kikkawa F; Maeda O; Suganuma N; Yamagata S; Yamagata T; Tomoda Y
    Br J Cancer; 1997; 75(12):1807-11. PubMed ID: 9192986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
    Suzuki M; Usui N; Furugen Y; Mitsuhasi N
    Int J Clin Oncol; 2001 Feb; 6(1):19-24. PubMed ID: 11706522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant cell-specific gelatinase activity in human endometrial carcinoma.
    Takemura M; Azuma C; Kimura T; Tokugawa Y; Miki M; Ono M; Saji F; Tanizawa O
    Cancer; 1992 Jul; 70(1):147-51. PubMed ID: 1318775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation.
    Zhang J; Salamonsen LA
    J Clin Endocrinol Metab; 2002 May; 87(5):2346-51. PubMed ID: 11994386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants.
    Marbaix E; Donnez J; Courtoy PJ; Eeckhout Y
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11789-93. PubMed ID: 1465400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative evaluation of active gelatinolytic sites in uterine endometrioid adenocarcinoma using film in situ zymography: association of stronger gelatinolysis with myometrial invasion.
    Zheng K; Nagai Y; Kishimoto T; Yamazawa K; Tate S; Nemori R; Hirai Y; Sekiya S; Ishikura H
    Jpn J Cancer Res; 2002 May; 93(5):516-22. PubMed ID: 12036447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
    Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
    Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues.
    Takemura M; Azuma C; Kimura T; Kanai T; Saji F; Tanizawa O
    Int J Gynaecol Obstet; 1994 Sep; 46(3):303-9. PubMed ID: 7806000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
    Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.
    Forsyth PA; Laing TD; Gibson AW; Rewcastle NB; Brasher P; Sutherland G; Johnston RN; Edwards DR
    J Neurooncol; 1998 Jan; 36(1):21-9. PubMed ID: 9525822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells.
    Yao PM; Delclaux C; d'Ortho MP; Maitre B; Harf A; Lafuma C
    Am J Respir Cell Mol Biol; 1998 Jun; 18(6):813-22. PubMed ID: 9618386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
    Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
    Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts.
    Wucherpfennig AL; Li YP; Stetler-Stevenson WG; Rosenberg AE; Stashenko P
    J Bone Miner Res; 1994 Apr; 9(4):549-56. PubMed ID: 8030443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.